66th ASH Annual Meeting: Implementation of Decentralized Clinical Trials

Symposia: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation Scientific Workshops

Room 4 (San Diego Convention Center)

Moderator:

and Uma Borate, MD, The Ohio State University

Disclosures:

Borate: Astellas: Consultancy; Beigene: Membership on an entity's Board of Directors or advisory committees; BMS: Consultancy; Takeda: Other: IDMC; Abbvie: Consultancy; Sumitomo: Consultancy; Rigel: Consultancy; Daiichi Sankyo: Consultancy; Incyte: Consultancy; Vincerx Pharma: Membership on an entity's Board of Directors or advisory committees; Novartis: Consultancy.

This session will discuss the practical considerations in the implementation of decentralized clinical trials, the challenges to implementation from an institutional and sponsor perspective with a panel discussion that will involve regulatory expertise.

Moderator Introduction

Uma Borate, MD

The Ohio State University, Columbus, OH

Innovative Decentralized Clinical Trial Designs

Giulia Petrone, MD, MBBS

Washington University, Saint Louis, MO

Challenges in Operationalizing Decentralized Clinical Trials: The Institutional Perspective

Irene Ghobrial, MD

Dana-Farber Cancer Institute, Boston, MA

The Sponsor Perspective of Decentralized Clinical Trials - Pleasure or Pain?

Ankit J. Kansagra, MD

University of Texas Southwestern Medical Center, Dallas, TX

Panel Discussion

See more of: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
See more of: Scientific Workshops

<< Previous Session | Next Session >>